IRS1 and cancer: Thus our systematic SPPS‐based approach towards the SAR analysis of this NRPS‐derived linear peptide has allowed the identification of a new and promising lead for use in the design of anti‐cancer therapeutics, and as a tool to study the role of IRS‐1 expression and F‐actin aggregation.